Analyst Scoreboard: 7 Ratings For Inspire Medical Systems
Portfolio Pulse from Benzinga Insights
In the past three months, 7 analysts have rated Inspire Medical Systems (NYSE:INSP), with a mix of bullish and somewhat bullish sentiments. The average 12-month price target is $222.86, a 6.7% decrease from the previous target. Analysts have adjusted their ratings and price targets based on market conditions and company performance. Inspire Medical Systems has shown a positive revenue growth rate of 29.65% but faces challenges with net margin and return on equity.
September 30, 2024 | 7:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Inspire Medical Systems has received mixed analyst ratings with a new average price target of $222.86, down 6.7% from the previous target. The company shows strong revenue growth but faces challenges in profitability and return on equity.
The mixed analyst ratings and the decrease in the average price target suggest a neutral short-term impact on INSP's stock price. The company's strong revenue growth is a positive indicator, but challenges in profitability and return on equity may offset this, leading to a balanced outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100